Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Zipnosis CEO to Speak at AGC's 2016 Boston Technology Growth Conference

Posted on: 14 Sep 16

PR Newswire

STAPLES, Minn., Sept. 14, 2016

STAPLES, Minn., Sept. 14, 2016 /PRNewswire/ -- Investors will gather on September 15th at AGC's 2016 Boston Technology Growth Conference to hear from Zipnosis CEO and co-founder Jon Pearce about the technology driving healthcare's accelerating transition beyond the four walls of the traditional provider facility. Pearce will participate in the panel discussion "The Evolution of Telemedicine to Virtual Care," sharing his insightful commentary on the forces that will make virtual care as ubiquitous as the doctor's waiting room—only far more profitable.

This transition comes as telemedicine itself is increasingly recognized as just one subset of the broader virtual care arena, which includes services from tele-consults to digital health coaching to remote patient monitoring and more. Companies with innovative platforms that support this wider array of virtual care offerings are now the vendors of choice for health systems and payers focused on expanding access and improving quality at a lower cost. These organizations are realizing that virtual care is their means to achieve what would otherwise be counter objectives.  

An entrepreneur and company to watch

2016 has been a year of accolades for Zipnosis and CEO Jon Pearce. Zipnosis was one of four companies recognized as an IDC Innovator in Virtual Care Solutions, 2016, and was also cited as one of the best places to work in the Minneapolis-St. Paul area by The Minneapolis/St. Paul Business Journal. Pearce was recently named one of the top "healthcare entrepreneurs to know" by Becker's Hospital Review. A well-known tech luminary in the Midwest, with roots in software engineering and venture investments analysis, Pearce's rare hybrid background has helped create a solid virtual care offering backed by a well-funded company.

The Zipnosis platform offers evidence-based, quality virtual care regardless of access point. It offers complete integration with hospital EMRs and portals, and is easily white-labeled as a virtual care service staffed by the provider's own clinicians and content to ensure continuity of care for patients. The platform enables fast, accurate and evidence-based diagnosis and treatment online, giving patients access to quality, convenient care.

AGC's 2016 Boston Technology Conference will be held on Thursday, September 15, at 99 High Street, 22nd floor, in Boston. The agenda for the program will feature between 175 and 200 CEOs from fast-growing private technology companies, along with individual company presentations and panel discussions led by industry experts on today's most relevant topics. To request an invitation, visit


Zipnosis partners with health systems nationwide to provide a white-labeled telemedicine virtual care platform, offering patients convenient access to care while improving clinician efficiency. Patients can be virtually treated for more than 90 conditions using an evidence-based adaptive interviews, phone or video, or when a rapid test like strep is needed, directed to visit a clinic with expedited service using the ZipTicket® boarding pass. Based in Minnesota, Zipnosis has more than 7 years of experience and data to help our partners rapidly launch and scale a market-leading virtual care solution. For more information, visit

For More Information:
Joy DiNaro
Amendola Communications for Zipnosis

Logo -


To view the original version on PR Newswire, visit:

SOURCE Zipnosis

PR Newswire

Last updated on: 14/09/2016

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.